{"nctId":"NCT00571727","briefTitle":"Long-Term Treatment With rhIGF-1 in GHIS","startDateStruct":{"date":"1991-05-20","type":"ACTUAL"},"conditions":["Growth Hormone Insensitivity Syndrome"],"count":92,"armGroups":[{"label":"mecasermin, injections BID of rhIGF-1","type":"EXPERIMENTAL","interventionNames":["Drug: mecasermin"]}],"interventions":[{"name":"mecasermin","otherNames":["Increlex"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Height \\<-2SD for age and gender\n* IGF-1 \\<-2SD for age and gender\n* Evidence of GH resistance\n\nExclusion Criteria:\n\n* closed epiphyses\n* prior active malignancy\n* major organ disfunction\n* treatment with medications that would diminish growth\n* clinically significant cardiac abnormalities","healthyVolunteers":false,"sex":"ALL","minimumAge":"2 Years","maximumAge":"21 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Annualized Height Velocity Up to 12 Years","description":"Height velocity is the difference between 2 height measurements, divided by years elapsed between measurements.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"1.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","spread":"1.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.9","spread":"1.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":"1.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"1.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"2.0"}]}]}]},{"type":"PRIMARY","title":"Number of Naive Participants With Height Velocity <5 cm/y at the End of 1 Year of Study Treatment","description":"Height measurements were performed using wall-mounted stadiometers for analysis of growth data.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Height Velocity Standard Deviation Score Up to 12 Years","description":"Center for disease control growth charts from the US were used as reference for age and gender-dependent mean and standard deviation. Height velocity-standard deviation score was calculated as height velocity minus reference mean height velocity divided by standard deviation of the reference mean height velocity. Greater height velocity standard deviation score indicates better outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.4","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.0","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"0.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"2.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"1.5"}]}]}]},{"type":"SECONDARY","title":"Height Standard Deviation Score Up to 12 Years","description":"Center for disease control growth charts from the US were used as reference for age and gender-dependent mean and standard deviation. Height standard deviation score was calculated as height minus reference mean height divided by standard deviation of the reference mean height. A higher height standard deviation score indicates a better outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.9","spread":"1.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.1","spread":"1.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.6","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.3","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.1","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.0","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.9","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.9","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.1","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.0","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.0","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.7","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.4","spread":"1.3"}]}]}]},{"type":"SECONDARY","title":"Approximate Increase in Height Over Expected for NaÃ¯ve Participants With Near-Adult Height","description":"Height measurements were performed using wall-mounted stadiometers for analysis of growth data.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.3","spread":"8.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":18,"n":92},"commonTop":["Hypoglycaemia","Injection site hypertrophy","Headache","Upper respiratory tract infection","Snoring"]}}}